Phase II Study (PK) of KRP-AB1102
Phase 2
- Conditions
- COPD
- Registration Number
- JPRN-jRCT2080221868
- Lead Sponsor
- Kyorin Pharmaceutical Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 13
Inclusion Criteria
Adult male COPD patients aged >40, and others.
Exclusion Criteria
- Current active tuberculopsis
- Patient hospitalized for an acute COPD exacerbation within the previous 3 months, and others.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method